Aperture Venture Partners IV, L.P. is 10% Owner at Trevi Therapeutics, Inc. (TRVI). They have made 1 open-market trade across 1 company since 2019, most recently 2019-05-09.
CIK 0001659119
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.1M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TRVI | 232,963 | $3.3M |
Shares reported on the most recent Form 4, priced at the 2019-05-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRVI | BUY | 2019-05-09 | 2019-05-13 | $10.00 | $1.1M | +12.5% | +3.2% | -36.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.